http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-56401-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
filingDate 2000-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_293d1e9d879599914dcc37195f6e67aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ebaad1592d2a03bdff8e7579ea361ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf69fdd1d37accd227f71ac42cb8174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe3aa3fb65f8a7b92ac878c72b7edb3
publicationDate 2004-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber YU-56401-A
titleOfInvention (1-PHENACY-3-PHENYL-3-PIPERIDYLETHYL) PIPERIDINE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract The invention relates to compounds of formula (I) and to their salts with inorganic and organic acids, to their solvates and / or hydrates, which show high affinity and high selectivity for human NK1 receptors of substance P. The invention also relates to a process for their production, to intermediates such as compounds of formula (VII) useful in their manufacture, to pharmaceutical compositions containing said products and to their use in the manufacture of medicaments for the treatment of all pathologies associated with substance P and human NK1 receptors.
priorityDate 1999-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36511
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820085
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21333
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6863
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100277053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID819276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24806
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281512

Total number of triples: 68.